1988
|
Sign up to set email alerts
Clinical stages of dementia and the dexamethasone suppression test
Search citation statements
Order By: Relevance
Paper Sections
Select...
6
1
0
0
Citation Types
0
2
0
0
Year Published
Range
1989
19892021
2021Publication Types
Select...
5
2
Relationship
0
7
Authors
Journals
Cited by 7 publications
(2 citation statements)
References 7 publications
0
2
0
0
Order By: Relevance
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Each stage corresponds to clinical phases of dementia, from normal (stage 1) to late dementia (stage 7), and are accompanied by a short description of characteristics. [24, 25].…”
Section: Methods
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Each stage corresponds to clinical phases of dementia, from normal (stage 1) to late dementia (stage 7), and are accompanied by a short description of characteristics. [24, 25].…”
Section: Methods
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Although a number of abnormalities have been reported in HPA axis activity in Alzheimer's disease (AD), e.g., decreased adrenocorticotropic hormone (ACTH) levels in cerebrospinal fluid (CSF) (Nappi et al, 1988;Suemaru et al, 1991), elevated urinary free cortisol (Maeda et al, 1991), elevated corticotropin-releasing factor (CRF) in CSF (Martignoni et al, 1990a(Martignoni et al, , 1990b, elevated rates of nonsuppression of cortisol in response to the dexamethasone suppression test (DST) (Bilikiewicz & Bidzan, 1990;Davous et al, 1988;Ferrier et al, 1988;Gierl et al, 1987;Gurevich et al, , 1990Hatzinger et al, 1995;Leake et al, 1990;Maeda et al, 1991;Masugi et al, 1989;Molchan et al, 1990;Oxenkrug et al, 1989;Parnetti et al, 1990;Serby et al, 1988;Siegel et al, 1989;Skare et al, 1990;Vollhardt et al, 1989), and elevated baseline cortisol levels (Masugi et al, 1989;O'Brien et al, 1996;Tollefson et al, 1989), others have failed to replicate these findings. Roelandts (1989) found no difference in ACTH estimations in the CSF of 17 patients with dementia.…”
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Each stage corresponds to clinical phases of dementia, from normal (stage 1) to late dementia (stage 7), and are accompanied by a short description of characteristics. [24, 25].…”
Section: Methods
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Although a number of abnormalities have been reported in HPA axis activity in Alzheimer's disease (AD), e.g., decreased adrenocorticotropic hormone (ACTH) levels in cerebrospinal fluid (CSF) (Nappi et al, 1988;Suemaru et al, 1991), elevated urinary free cortisol (Maeda et al, 1991), elevated corticotropin-releasing factor (CRF) in CSF (Martignoni et al, 1990a(Martignoni et al, , 1990b, elevated rates of nonsuppression of cortisol in response to the dexamethasone suppression test (DST) (Bilikiewicz & Bidzan, 1990;Davous et al, 1988;Ferrier et al, 1988;Gierl et al, 1987;Gurevich et al, , 1990Hatzinger et al, 1995;Leake et al, 1990;Maeda et al, 1991;Masugi et al, 1989;Molchan et al, 1990;Oxenkrug et al, 1989;Parnetti et al, 1990;Serby et al, 1988;Siegel et al, 1989;Skare et al, 1990;Vollhardt et al, 1989), and elevated baseline cortisol levels (Masugi et al, 1989;O'Brien et al, 1996;Tollefson et al, 1989), others have failed to replicate these findings. Roelandts (1989) found no difference in ACTH estimations in the CSF of 17 patients with dementia.…”
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Each stage corresponds to clinical phases of dementia, from normal (stage 1) to late dementia (stage 7), and are accompanied by a short description of characteristics. [24, 25].…”
Section: Methods
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Although a number of abnormalities have been reported in HPA axis activity in Alzheimer's disease (AD), e.g., decreased adrenocorticotropic hormone (ACTH) levels in cerebrospinal fluid (CSF) (Nappi et al, 1988;Suemaru et al, 1991), elevated urinary free cortisol (Maeda et al, 1991), elevated corticotropin-releasing factor (CRF) in CSF (Martignoni et al, 1990a(Martignoni et al, , 1990b, elevated rates of nonsuppression of cortisol in response to the dexamethasone suppression test (DST) (Bilikiewicz & Bidzan, 1990;Davous et al, 1988;Ferrier et al, 1988;Gierl et al, 1987;Gurevich et al, , 1990Hatzinger et al, 1995;Leake et al, 1990;Maeda et al, 1991;Masugi et al, 1989;Molchan et al, 1990;Oxenkrug et al, 1989;Parnetti et al, 1990;Serby et al, 1988;Siegel et al, 1989;Skare et al, 1990;Vollhardt et al, 1989), and elevated baseline cortisol levels (Masugi et al, 1989;O'Brien et al, 1996;Tollefson et al, 1989), others have failed to replicate these findings. Roelandts (1989) found no difference in ACTH estimations in the CSF of 17 patients with dementia.…”
mentioning
confidence: 99%